A Phase III, Open-Label, Multicenter, Two-Arm, Randomized Study To Investigate The Efficacy And Safety Of Cobimetinib Plus Atezolizumab Versus Pembrol
Posted Date: May 15, 2019
- Investigator: Rekha Chaudhary
- Type of Study: Drug
F. Hoffmann-La Roche CO39722
Criteria:
To Be Eligible To Participate In This Study, Patients Must Have Type Of Skin Cancer Called Melanoma
Keywords:
Cancer, Co39722, Melanoma, Phase Iii
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com